Used for bone marrow transplant for a variety of hematologic disorders.
Identified by expression of CD34 and CD133.
Endothelial progenitor cells that reside in the bone marrow can promote neovascularization by secreting proangiogenic growth factors and can stimulate re-endothelialization and contribute to vascular homeostasis and possibly myogenesis.